Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug combination for reducing blood sugar and lipid levels

A composition and blood lipid technology, applied in the direction of drug combination, active ingredients of iodine compounds, active ingredients of heterocyclic compounds, etc., can solve the problems of few health food targets, high cost and high price, and achieve no incompatibility, low cost, Effect of lowering blood sugar and blood fat

Inactive Publication Date: 2009-12-09
BEIJING LIQIANQIU SCI & TECH DEV
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] There are many types of drugs or health products currently used to lower blood sugar and blood lipids, but there are many drugs with toxic side effects, and there are few health food targets and links are lacking, which need to be improved, and the cost and price are high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug combination for reducing blood sugar and lipid levels
  • Drug combination for reducing blood sugar and lipid levels

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Berberine 680mg,

[0028] Vitamin B 1 3 mg,

[0029] Vitamin B 2 3 mg,

[0030] Vitamin B 6 2 mg,

[0031] Zinc lactate (calculated as trace element zinc) 10mg,

[0032] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0033] Chromium nicotinate (calculated as trace element chromium) 0.01mg,

[0034] Potassium iodate (calculated as trace element iodine) 0.1mg,

[0035] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0036] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 2

[0038] Berberine 700mg,

[0039] Vitamin B 1 3 mg,

[0040] Vitamin B 2 3 mg,

[0041] Vitamin B 6 2 mg,

[0042] Niacinamide 10mg,

[0043] Zinc lactate (calculated as trace element zinc) 8mg,

[0044] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0045] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0046] Potassium iodate (calculated as trace element iodine) 0.1mg,

[0047] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0048] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 3

[0050] Berberine 800mg,

[0051] Vitamin B 1 3 mg,

[0052] Vitamin B 2 3 mg,

[0053] Vitamin B 6 2 mg,

[0054] Niacinamide 10mg,

[0055] Zinc lactate (calculated as trace element zinc) 8mg,

[0056] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0057] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0058] Potassium iodate (calculated as trace element iodine) 0.1mg,

[0059] Sodium molybdate (calculated as trace element molybdenum) 0.03mg,

[0060] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0061] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A drug combination for reducing blood sugar and lipid levels comprises berberine, vitamin B complex, vitamin E and trace elements such as zinc, selenium, chromium, copper, molybdenum, iodine and manganese. The drug combination is mainly suitable for the population suffering from high blood sugar and lipid levels, has good effects on reducing blood sugar and lipid levels and can be taken for long term or according to the courses of treatment.

Description

Technical field: [0001] The invention relates to the technical field of medicine and health products; especially a pharmaceutical composition for lowering blood sugar and blood fat. Background technique: [0002] The composition includes berberine, complex vitamin B, vitamin E and trace elements zinc, selenium, chromium, copper, molybdenum, iodine and manganese. [0003] Berberine is an alkaloid extracted from natural medicinal materials Coptis chinensis, Cortex Phellodendron and other drugs containing berberine, and it can also be synthesized artificially; it is commonly used in modern clinics to treat bacillary dysentery, acute gastroenteritis and other diseases; some scholars have shown that Coptis chinensis can improve high blood pressure. Insulin resistance in fat-fed rats increased the synthesis of glycogen in the liver; clinical reports showed significant differences in the treatment of diabetes with berberine alone; berberine not only had a significant hypoglycemic e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/24A61P3/06A61P3/10A61K31/19A61K31/194A61K31/197A61K31/355A61K31/4188A61K31/4415A61K31/455A61K31/51A61K31/519A61K31/525A61K31/714A61K33/04A61K33/18
Inventor 陈欣晶
Owner BEIJING LIQIANQIU SCI & TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com